OTC Markets Group

Edison Investment Research is terminating coverage on OTC Markets Group. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Equities

Equities by Sector

Sectors

Thematics

Latest

Inside the mind of investors: International Biotechnology Trust

Borussia Dortmund – executive interviews

UK equities: A generational opportunity?

Audiovisual

Latest

Vantage: Gresham House Energy Storage Fund – Navigating challenges in energy storage

IP Group – executive interview

Georgia Capital in 60 seconds

About Edison

About Edison

Careers

OTC Markets Group (US: OTCM)

Latest Insights

OTC Markets Group — Q122 – net income up 11%, but costs start to bite

OTC Markets Group — Q421 was another beat, 2022 is more uncertain

OTC Markets Group — Hitting it out of the ballpark

OTC Markets Group — Revenue beat, positive business mix

Sector

Research

OTC Markets Group — Q421 was another beat, 2022 is more uncertain

OTC Markets Group — Hitting it out of the ballpark

OTC Markets Group — Q122 – net income up 11%, but costs start to bite

OTC Markets Group — Revenue beat, positive business mix

OTC Markets Group — Long term focus remains as volumes spike

OTC Markets Group — Focus remains on long-term value

OTC Markets Group — A further estimate upgrade

OTC Markets Group — Trading well and keeping its long-term focus

OTC Markets Group — Staying on course

OTC Markets Group — Keeping focus amid near-term uncertainty

Executive interview – OTC Markets Group

Thematics

A net zero perspective – Investing in sustainability, technology & innovation

Banco Angolano de Investimentos (BAI) – Money-centre bank with lending optionality

South African life assurers: Where is the growth?

Deutsches Eigenkapitalforum (EKF) 2023 financials and investment companies

Subscribe to Edison